Global Markets and Technologies for Molecular Imaging Devices

Report Code: HLC146A

Publish Date: Nov 2013

Publisher: BCC Publishing

Category: Health Maintenance

Customize This Report

Single User License: $2500

Member Price: FREE

EXPLORE OFFERS

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

The global market for molecular imaging devices was valued at $2 billion in 2012. This market is expected to reach $2.2 billion in 2013 and nearly $3 billion by 2018, with a compound annual growth rate (CAGR) of 6.2% for the period of 2013 to 2018.

Report Includes

  • An overview of the global market for molecular imaging devices, which offers a new dimension to medicine as it evolves toward more personalized forms of treatment.
  • Analyses of global market trends, with data from 2012, estimates for 2013, and projections of CAGRs for the period 2013 to 2018.
  • Examination of factors driving growth, market figures related to the current value of molecular imaging equipment, market shares, and key players.
  • Reviews of the competitive landscape, leading pipeline products, pricing, and technology offerings.
  • Identification of the types of molecular imaging devices, including stand-alone planar imaging, PET, PET-CT, SPECT, and SPECT-CT.
  • Comprehensive company profiles of major manufacturers.

SCOPE OF STUDY

This report is a comprehensive business tool designed to provide an in–depth look at molecular imaging devices for various applications. The geographic scope of the report is global, with a special emphasis on individual regions. The report describes the industry, its relationship to the healthcare industry and its participants and trends for the future.

Categories discussed in the report include:

  • Planar scintillation cameras.
  • PET.
  • PET–CT.
  • SPECT.
  • SPECT–CT.

Applications discussed in the report include:

  • Oncology.
  • Cardio and vascular.
  • Neurology.
  • Others (brain imaging, tumors, Alzheimer’s, aneurysms, bone scanning, irregular or inadequate functioning of organs, myocardial perfusion imaging).

All categories are discussed in detail, describing each segment, identifying current products in the market, measuring market size, identifying market drivers, forecasting for 2013 through 2018 and assessing the competitors and competitor market shares. For country–level breakdown of segments, only the base year 2013 and projections through 2018 are shown in the data tables.

The market evaluated in this study pertains to new nuclear medicine and PET imaging systems that are developed and approved for human clinical use. The market sizing only takes into account the new equipment. Options/upgrades or refurbished/remarketed equipment have not been accounted for in the quantitative estimates and forecasts provided in the study. Ancillary products and services, including contrast agents, radiopharmaceuticals, licensing fees, cyclotrons, radiotherapy equipment, and mobile imaging devices have been excluded from the study. Also, integrated PET/MRI systems are not accounted for in forecasts pertaining to the market segment.

ANALYST CREDENTIALS

Smruti Munshi is a research analyst who has specialized in the medical technologies space for the last five years. She focuses on monitoring and analyzing emerging trends, technologies, competitive benchmarking and market dynamics in the medical imaging industry. She has worked on several projects spanning the EMEA markets ranging from market insights, and industry overviews to comprehensive marketing and technology–oriented custom consulting. Ms. Munshi has an M.S. in Biomedical Engineering and a B.S. in Instrumentation and Control Engineering.

Need a custom data table, graph, region, segment, companies or complete report? CUSTOMIZE NOW
Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Global Markets and Technologies for Molecular Imaging Devices240Free
Chapter- 1: INTRODUCTION3Free
Chapter- 2: SUMMARY4Free
Chapter- 3: AN INTRODUCTION TO MOLECULAR IMAGING20Free
Chapter- 4: GLOBAL MARKET SIZE AND GROWTH 13Free
Chapter- 5: GLOBAL MARKET BY DEVICE TYPE AND APPLICATION9Free
Chapter- 6: INDUSTRY STRUCTURE, TECHNOLOGY TRENDS: FUSION TECHNOLOGIES AND MARKET SHARE19Free
Chapter- 7: PATENT ANALYSIS22Free
Chapter- 8: REGULATIONS AND REIMBURSEMENT17Free
Chapter- 9: THE NORTH AMERICAN MARKET17Free
Chapter- 10: THE EUROPEAN MARKET 41Free
Chapter- 11: THE ASIAN MARKET19Free
Chapter- 12: EMERGING MARKETS22Free
Chapter- 13: MARKET STRATEGIES STRATEGIC RECOMMENDATIONS12Free
Chapter- 14: C. CRAMER & CO. GMBH22Free

Related Reports

Medical Magnetic Resonance Imaging (MRI): Technologies and Global Markets

Published - Sep 2013 | Publisher - Peggy Lehr | Code - HLC078B

The global market for MRI systems was $4.9 billion in 2012. This market is projected to reach $5.4 billion in 2013 and $6.9 billion by 2018, at an estimated compound annual growth rate (CAGR) of 5% from 2013 to 2018.

Global Markets and Technologies for Molecular, Nanoscale and Atomic Imaging

Published - Mar 2013 | Publisher - Shalini Shahani Dewan | Code - NAN046B

The global molecular, atomic and nanoscale imaging market was nearly $3.1 billion in 2011 and nearly $3.2 billion in 2012. This market is expected to grow to $4.4 billion by 2017, a compound annual growth rate (CAGR) of 6.8% from 2012 to 2017.

Global Markets for CT Scanners

Published - Oct 2012 | Publisher - Smruti Munshi | Code - HLC024A

The global market for CT scanners was valued at $3.4 billion in 2011 and should reach nearly $3.7 billion in 2012. Total market value is expected to reach nearly $5.1 billion in 2017 after increasing at a five-year compound annual growth rate (CAGR) of 6.7%.

Medical Imaging Technologies for Oncology Diagnostics: The Global Market

Published - Mar 2011 | Publisher - Valerie Kellogg | Code - HLC074A

The global market for diagnostic imaging equipment for oncology reached more than $11.6 billion in 2010 and, despite the global recession, is forecast to grow to about $14.8 billion by 2015, an overall compound annual growth rate (CAGR) of 5% for 2010 through 2015.

Recent Reports

Conventional and Alternative Pain Treatment Markets

Published - Nov 2024 | Publisher - Partha Sarathi Das | Code - HLC266B

The global market for conventional and alternative pain treatment is expected to grow from $96.2 billion in 2024 and is projected to reach $144.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.4% during the forecast period of 2024 to 2029.

CRISPR Technology: Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - HLC258C

The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.

Chronic Disease Management: Therapeutics, Device Technologies and Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - HLC239C

The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.

Medical Devices: Technologies and Global Markets

Published - Oct 2024 | Publisher - Partha Sarathi Das | Code - HLC170F

The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.

Point-of-Care Diagnostics: Technologies and Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - HLC043H

The global market for point-of-care diagnostics was valued at $36.9 billion in 2023. It is expected to grow from $40.6 billion in 2024 to $65.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% from 2024 through 2029.

Top Trending Reports

AI in Clinical and Molecular Diagnostics Market

Published - Oct 2024 | Publisher - BCC Publishing | Code - BIO261A

The global market for AI in clinical and molecular diagnostics is expected to grow from $2.6 billion in 2024 and is projected to reach $8.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 27.6% during the forecast period of 2024 to 2029.

Point-of-Care Diagnostics: Technologies and Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - HLC043H

The global market for point-of-care diagnostics was valued at $36.9 billion in 2023. It is expected to grow from $40.6 billion in 2024 to $65.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% from 2024 through 2029.

Medical Devices: Technologies and Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - HLC170F

The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.

Global Artificial Intelligence (AI) Market: Investments vs Potential

Published - Aug 2024 | Publisher - BCC Publishing | Code - IFT189C

The global market for artificial intelligence (AI) is estimated to increase from $148.8 billion in 2023 to reach $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 39.7% from 2024 through 2029.

CRISPR Technology: Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - HLC258C

The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Global Markets and Technologies for Molecular Imaging Devices
Customize Report